{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T06:19:26Z","timestamp":1793773166771,"version":"4.6.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T00:00:00Z","timestamp":1655769600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T00:00:00Z","timestamp":1655769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006041","name":"Innovate UK","doi-asserted-by":"publisher","award":["56969"],"award-info":[{"award-number":["56969"]}],"id":[{"id":"10.13039\/501100006041","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Neutrophilia and an elevated neutrophil:lymphocyte ratio are both characteristic features of severe COVID-19 infection. However, functional neutrophil responses have been poorly investigated in this setting. We utilised a novel PMA-based stimulation assay to determine neutrophil-derived reactive oxygen species (ROS) generation in patients with severe COVID-19 infection, non-COVID related sepsis and healthy study participants. ROS production was markedly elevated in COVID-19 patients with median values ninefold higher than in healthy controls and was particularly high in patients on mechanical ventilation. ROS generation correlated strongly with neutrophil count and elevated levels were also seen in patients with non-COVID related sepsis. Relative values, adjusted for neutrophil count, were high in both groups but extreme low or high values were seen in two patients who died shortly after testing, potentially indicating a predictive value for neutrophil function. Our results show that the high levels of neutrophils observed in patients with COVID-19 and sepsis exhibit functional capacity for ROS generation. This may contribute to the clinical features of acute disease and represents a potential novel target for therapeutic intervention.<\/jats:p>","DOI":"10.1038\/s41598-022-13825-7","type":"journal-article","created":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T15:39:56Z","timestamp":1655825996000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":83,"title":["High generation of reactive oxygen species from neutrophils in patients with severe COVID-19"],"prefix":"10.1038","volume":"12","author":[{"given":"Tonny","family":"Veenith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Le Breuilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Whitehouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Gao-Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niharika","family":"Duggal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet M.","family":"Lord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rubina","family":"Mian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sarphie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Moss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,21]]},"reference":[{"key":"13825_CR1","doi-asserted-by":"publisher","first-page":"m1198","DOI":"10.1136\/bmj.m1198","volume":"368","author":"RE Jordan","year":"2020","unstructured":"Jordan, R. E. & Adab, P. Cheng KK (2020) COVID-19: Risk factors for severe disease and death. BMJ 368, m1198. https:\/\/doi.org\/10.1136\/bmj.m1198 (2020).","journal-title":"BMJ"},{"key":"13825_CR2","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1056\/NEJMoa2100433","volume":"384","author":"AC Gordon","year":"2021","unstructured":"Gordon, A. C. et al. Interleukin-6 receptor antagonists in critically ill patients with COVID-19. N. Engl. J. Med. 384, 1491\u2013502. https:\/\/doi.org\/10.1056\/NEJMoa2100433 (2021).","journal-title":"N. Engl. J. Med."},{"key":"13825_CR3","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1084\/jem.20122220","volume":"210","author":"A Mocsai","year":"2013","unstructured":"Mocsai, A. Diverse novel functions of neutrophils in immunity, inflammation, and beyond. J. Exp. Med. 210, 1283\u20131299 (2013).","journal-title":"J. Exp. Med."},{"issue":"3","key":"13825_CR4","doi-asserted-by":"publisher","first-page":"e1004651","DOI":"10.1371\/journal.ppat.1004651","volume":"11","author":"P Kruger","year":"2015","unstructured":"Kruger, P. et al. Neutrophils: Between host defence, immune modulation, and tissue injury. PLoS Pathog. 11(3), e1004651. https:\/\/doi.org\/10.1371\/journal.ppat.1004651 (2015).","journal-title":"PLoS Pathog."},{"key":"13825_CR5","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1186\/s13054-020-03374-8","volume":"24","author":"X Li","year":"2020","unstructured":"Li, X., Liu, C. & Mao, Z. Predictive values of neutrophil-to-lymphocyte ratio on disease severity and mortality in COVID-19 patients: A systematic review and meta-analysis. Crit. Care 24, 647 (2020).","journal-title":"Crit. Care"},{"key":"13825_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.572009","volume":"11","author":"C-C Chiang","year":"2020","unstructured":"Chiang, C.-C., Korinek, M., Cheng, W.-J. & Hwang, T.-S. Targeting neutrophils to treat acute respiratory distress syndrome in coronavirus disease. Front. Pharmacol. 11, 572009. https:\/\/doi.org\/10.3389\/fphar.2020.572009 (2020).","journal-title":"Front. Pharmacol."},{"issue":"7","key":"13825_CR7","doi-asserted-by":"publisher","first-page":"448","DOI":"10.14740\/jocmr4240","volume":"12","author":"AS Chan","year":"2020","unstructured":"Chan, A. S. & Rout, A. Use of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in COVID-19. J. Clin. Med. Res. 12(7), 448\u201353. https:\/\/doi.org\/10.14740\/jocmr4240 (2020).","journal-title":"J. Clin. Med. Res."},{"key":"13825_CR8","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","volume":"581","author":"X Zheng","year":"2020","unstructured":"Zheng, X., Fan, Q. & Wang, L. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature 581, 215\u2013220. https:\/\/doi.org\/10.1038\/s41586-020-2180-5 (2020).","journal-title":"Nature"},{"issue":"1","key":"13825_CR9","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s40001-020-00432-3","volume":"25","author":"S Ghahramani","year":"2020","unstructured":"Ghahramani, S. et al. Laboratory features of severe vs. non-severe COVID-19 patients in Asian populations: A systematic review and meta-analysis. Eur. J. Med. Res. 25(1), 30. https:\/\/doi.org\/10.1186\/s40001-020-00432-3 (2020).","journal-title":"Eur. J. Med. Res."},{"issue":"10","key":"13825_CR10","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1002\/jmv.25819","volume":"92","author":"FA Lagunas-Rangel","year":"2020","unstructured":"Lagunas-Rangel, F. A. Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis. J. Med. Virol. 92(10), 1733\u20131734. https:\/\/doi.org\/10.1002\/jmv.25819 (2020).","journal-title":"J. Med. Virol."},{"key":"13825_CR11","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41577-020-0407-1","volume":"20","author":"M Laforge","year":"2020","unstructured":"Laforge, M. et al. Tissue damage from neutrophil-induced oxidative stress in COVID-19. Nat. Rev. Immunol. 20, 515\u2013516 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"13825_CR12","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/S2213-2600(20)30243-5","volume":"8","author":"SE Fox","year":"2020","unstructured":"Fox, S. E. et al. Pulmonary and cardiac pathology in COVID-19: The first autopsy series from New Orleans. Lancet Respir. Med. 8, 681\u20136. https:\/\/doi.org\/10.1016\/S2213-2600(20)30243-5 (2020).","journal-title":"Lancet Respir. Med."},{"issue":"5","key":"13825_CR13","doi-asserted-by":"publisher","first-page":"411","DOI":"10.3760\/cma.j.cn112151-20200312-00193","volume":"49","author":"XH Yao","year":"2020","unstructured":"Yao, X. H. et al. A pathological report of three COVID-19 cases by minimal invasive autopsies. Zhonghua Bing Li Xue Za Zhi 49(5), 411\u2013417. https:\/\/doi.org\/10.3760\/cma.j.cn112151-20200312-00193 (2020).","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"13825_CR14","doi-asserted-by":"publisher","first-page":"e2020065","DOI":"10.1084\/jem.20200652","volume":"217","author":"BJ Barnes","year":"2020","unstructured":"Barnes, B. J. et al. Targeting potential drivers of COVID-19: Neutrophil extracellular traps. J. Exp. Med. 217, e2020065. https:\/\/doi.org\/10.1084\/jem.20200652 (2020).","journal-title":"J. Exp. Med."},{"issue":"5","key":"13825_CR15","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1152\/physiolgenomics.00033.2020","volume":"52","author":"RM Golonka","year":"2020","unstructured":"Golonka, R. M. et al. Harnessing innate immunity to eliminate SARS-CoV-2 and ameliorate COVID-19 disease. Physiol. Genom. 52(5), 217\u2013221. https:\/\/doi.org\/10.1152\/physiolgenomics.00033.2020 (2020).","journal-title":"Physiol. Genom."},{"key":"13825_CR16","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1189\/jlb.1012544","volume":"94","author":"S Dupre-Crochet","year":"2013","unstructured":"Dupre-Crochet, S., Erard, M. & N\u00fc\u03b2e, O. ROS production in phagocytes: Why, when, and where?. J. Leukoc. Biol. 94, 657\u2013670. https:\/\/doi.org\/10.1189\/jlb.1012544 (2013).","journal-title":"J. Leukoc. Biol."},{"key":"13825_CR17","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3389\/fcimb.2017.00373","volume":"7","author":"GT Nguyen","year":"2017","unstructured":"Nguyen, G. T., Green, E. R. & Mecsas, J. Neutrophils to the ROScue: Mechanisms of NADPH oxidase activation and bacterial resistance. Front. Cell Infect. Microbiol. 7, 373. https:\/\/doi.org\/10.3389\/fcimb.2017.00373 (2017).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"13825_CR18","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nri1312","volume":"4","author":"JD Lambeth","year":"2004","unstructured":"Lambeth, J. D. NOX enzymes and the biology of reactive oxygen. Nat. Rev. Immunol. 4, 181\u2013189. https:\/\/doi.org\/10.1038\/nri1312 (2004).","journal-title":"Nat. Rev. Immunol."},{"key":"13825_CR19","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/jlb.67.3.396","volume":"67","author":"A Karlsson-Bengtsson","year":"2000","unstructured":"Karlsson-Bengtsson, A., Nixon, J. & McPhail, L. Phorbol myristate acetate induces neutrophil NADPH-oxidase activity by two separate signal transduction pathways: Dependent or independent of phosphatidylinositol 3-kinase. J. Leukoc. Biol. 67, 396\u2013404. https:\/\/doi.org\/10.1002\/jlb.67.3.396 (2000).","journal-title":"J. Leukoc. Biol."},{"issue":"5","key":"13825_CR20","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nri3423","volume":"13","author":"C Nathan","year":"2013","unstructured":"Nathan, C. & Cunningham-Bussel, A. Beyond oxidative stress: An immunologist\u2019s guide to reactive oxygen species. Nat. Rev. Immunol. 13(5), 349\u201361. https:\/\/doi.org\/10.1038\/nri3423 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"13825_CR21","doi-asserted-by":"publisher","first-page":"e1724","DOI":"10.3791\/1724","volume":"36","author":"V Brinkmann","year":"2010","unstructured":"Brinkmann, V., Laube, B., Abu Abed, U., Goosmann, C. & Zychlinksky, A. Neutrophil extracellular traps: How to generate and visualize them. J. Vis. Exp. 36, e1724. https:\/\/doi.org\/10.3791\/1724 (2010).","journal-title":"J. Vis. Exp."},{"issue":"3","key":"13825_CR22","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1084\/jem.20110367","volume":"208","author":"E Naik","year":"2011","unstructured":"Naik, E. & Dixit, V. M. Mitochondrial reactive oxygen species drive proinflammatory cytokine production. J. Exp. Med. 208(3), 417\u2013420. https:\/\/doi.org\/10.1084\/jem.20110367 (2011).","journal-title":"J. Exp. Med."},{"key":"13825_CR23","doi-asserted-by":"publisher","first-page":"448","DOI":"10.3389\/fimmu.2014.00448","volume":"5","author":"A Sheshachalam","year":"2014","unstructured":"Sheshachalam, A., Srivastava, N., Mitchell, T., Lacy, P. & Eitzen, G. Granule protein processing and regulated secretion in neutrophils. Front. Immunol. 5, 448. https:\/\/doi.org\/10.3389\/fimmu.2014.00448 (2014).","journal-title":"Front. Immunol."},{"key":"13825_CR24","doi-asserted-by":"publisher","first-page":"110102","DOI":"10.1016\/j.mehy.2020.110102","volume":"143","author":"R Cecchini","year":"2020","unstructured":"Cecchini, R. & Cecchini, A. L. SARS-CoV-2 infection pathogenesis is related to oxidative stress as a response to aggression. Med. Hypotheses 143, 110102. https:\/\/doi.org\/10.1016\/j.mehy.2020.110102 (2020).","journal-title":"Med. Hypotheses"},{"issue":"4","key":"13825_CR25","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1113\/eph8802571","volume":"88","author":"GW McLaren","year":"2003","unstructured":"McLaren, G. W. et al. Leukocyte coping capacity: A novel technique for measuring the stress response in vertebrates. Exp. Physiol. 88(4), 541\u20136. https:\/\/doi.org\/10.1113\/eph8802571 (2003).","journal-title":"Exp. Physiol."},{"issue":"1","key":"13825_CR26","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cellimm.2010.02.011","volume":"263","author":"GK Shelton-Rayner","year":"2010","unstructured":"Shelton-Rayner, G. K., Macdonald, D. W., Chandler, S., Robertson, D. & Mian, R. Leukocyte reactivity as an objective means of quantifying mental loading during ergonomic evaluation. Cell. Immunol. 263(1), 22\u201330. https:\/\/doi.org\/10.1016\/j.cellimm.2010.02.011 (2010).","journal-title":"Cell. Immunol."},{"key":"13825_CR27","volume-title":"Repurposing the Oxford MediStress Leukocyte Coping Capacity\u2122 Assay as a Novel Point-of-Care Biomarker of Neutrophil Function","author":"JN Fullerton","year":"2019","unstructured":"Fullerton, J. N. et al. Repurposing the Oxford MediStress Leukocyte Coping Capacity\u2122 Assay as a Novel Point-of-Care Biomarker of Neutrophil Function (Presentation British Pharmacological Society, 2019)."},{"issue":"11","key":"13825_CR28","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1038\/nm.2538","volume":"17","author":"C Weber","year":"2011","unstructured":"Weber, C. & Noels, H. Atherosclerosis: Current pathogenesis and therapeutic options. Nat. Med. 17(11), 1410\u201322. https:\/\/doi.org\/10.1038\/nm.2538 (2011).","journal-title":"Nat. Med."},{"key":"13825_CR29","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nri.2017.10","volume":"17","author":"O Soehnlein","year":"2017","unstructured":"Soehnlein, O., Steffens, S., Hidalgo, A. & Weber, C. Neutrophils as protagonists and targets in chronic inflammation. Nat. Rev. Immunol. 17, 248\u2013261. https:\/\/doi.org\/10.1038\/nri.2017.10 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"13825_CR30","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3389\/fcimb.2017.00217","volume":"7","author":"I Miralda","year":"2017","unstructured":"Miralda, I., Uriarte, S. M. & McLeish, K. R. Multiple phenotypic changes define neutrophil priming. Front. Cell Infect. Microbiol 7, 217. https:\/\/doi.org\/10.3389\/fcimb.2017.00217 (2017).","journal-title":"Front. Cell Infect. Microbiol"},{"key":"13825_CR31","doi-asserted-by":"publisher","first-page":"19630","DOI":"10.1038\/s41598-020-76781-0","volume":"10","author":"A Arcanjo","year":"2020","unstructured":"Arcanjo, A., Logullo, J. & Menezes, C. C. B. The emerging role of neutrophil extracellular traps in severe acute respiratory syndrome coronavirus 2 (COVID-19). Sci. Rep. 10, 19630. https:\/\/doi.org\/10.1038\/s41598-020-76781-0 (2020).","journal-title":"Sci. Rep."},{"issue":"6","key":"13825_CR32","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/j.cell.2020.08.001","volume":"182","author":"J Schulte-Schrepping","year":"2020","unstructured":"Schulte-Schrepping, J. et al. Severe COVID-19 is marked by a dysregulated myeloid cell compartment. Cell 182(6), 1419\u20131440. https:\/\/doi.org\/10.1016\/j.cell.2020.08.001 (2020).","journal-title":"Cell"},{"issue":"10","key":"13825_CR33","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.3390\/cells9102206","volume":"9","author":"Z Parackova","year":"2020","unstructured":"Parackova, Z. et al. Disharmonic inflammatory signatures in COVID-19 augmented neutrophils\u2019 but impaired monocytes\u2019 and dendritic cells\u2019 responsiveness. Cell 9(10), 2206. https:\/\/doi.org\/10.3390\/cells9102206 (2020).","journal-title":"Cell"},{"key":"13825_CR34","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13073-020-00823-5","volume":"13","author":"AC Aschenbrenner","year":"2021","unstructured":"Aschenbrenner, A. C. et al. (2021) Disease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patients. Genome Med. 13, 7. https:\/\/doi.org\/10.1186\/s13073-020-00823-5 (2021).","journal-title":"Genome Med."},{"issue":"15","key":"13825_CR35","doi-asserted-by":"publisher","first-page":"953","DOI":"10.21037\/atm-19-3173","volume":"8","author":"E Urrechaga","year":"2020","unstructured":"Urrechaga, E. Reviewing the value of leukocytes cell population data (CPD) in the management of sepsis. Ann. Transl. Med. 8(15), 953. https:\/\/doi.org\/10.21037\/atm-19-3173 (2020).","journal-title":"Ann. Transl. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13825-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13825-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13825-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T01:13:29Z","timestamp":1669338809000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13825-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,21]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["13825"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-13825-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,21]]},"assertion":[{"value":"16 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Authors Mian and Sarphie declare that they are directors and principal shareholders of Seroxo Ltd, a private company developing clinical applications of the LIT\u2122 system. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10484"}}